The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Deep molecular response to gilteritinib to improve survival in FLT3 mutation-positive relapsed/refractory acute myeloid leukemia.
 
Jessica K. Altman
Consulting or Advisory Role - American Society of Hemotology; Bristol-Myers Squibb; Janssen; National Comprehensive Cancer Network; Syros Pharmaceuticals
 
Alexander E. Perl
Consulting or Advisory Role - Ambit BioSciences; Arog; Astellas Pharma; Daiichi Sankyo
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; ARIAD; BiolineRx; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Teva (Inst)
 
Catherine Choy Smith
Research Funding - Astellas Pharma
 
Mark Robert Litzow
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Research Funding - Actinium Pharmaceuticals; Amgen; Astellas Pharma
Travel, Accommodations, Expenses - Amgen
 
Jason E Hill
Employment - Astellas Pharma
Stock and Other Ownership Interests - Ligacept
Patents, Royalties, Other Intellectual Property - Ligacept LLC (Inst); Targeted Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Astellas Pharma
 
Richard A. Larson
Consulting or Advisory Role - Amgen; ARIAD; Bristol-Myers Squibb; Celgene; CVS Caremark; Jazz Pharmaceuticals; Novartis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst)
 
Charles Liu
Employment - Astellas Pharma (I)
Stock and Other Ownership Interests - Astellas Pharma
Travel, Accommodations, Expenses - Astellas Pharma
 
Ellen K. Ritchie
Consulting or Advisory Role - Celgene; Incyte; Novartis; Pfizer
Speakers' Bureau - ARIAD; Celgene; Incyte; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst); NS Pharma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis
 
Stephen Anthony Strickland
Honoraria - Astellas Pharma
Consulting or Advisory Role - Alexion Pharmaceuticals; Baxalta; Boehringer Ingelheim; CTI; Daiichi Sankyo; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Research Funding - Boehringer Ingelheim (Inst); Sunesis Pharmaceuticals (Inst)
 
Eunice S. Wang
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Seagen; Sigma-Tau; Spectrum Pharmaceuticals
Speakers' Bureau - Incyte
Research Funding - Immunogen (Inst)
 
Andreas Neubauer
No Relationships to Disclose
 
Giovanni Martinelli
Consulting or Advisory Role - ARIAD; Celgene; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Erkut Bahceci
Employment - Astellas Pharma
 
Mark J. Levis
Honoraria - Agios; Daiichi Sankyo; Novartis
Consulting or Advisory Role - Agios; Daiichi Sankyo; Novartis